NF-E2-mediated enhancement of megakaryocytic differentiation and platelet production in vitro and in vivo

Experimental Hematology

Volumn 36, Issue 1, 2008, Pages 78-92

  Fock, Ee ling ^a   Yan, Feng ^a   Pan, Shu ^a   Chong, Beng H ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; ANTIGEN; CD42A ANTIGEN; ENHANCED GREEN FLUORESCENT PROTEIN; FIBRINOGEN RECEPTOR; FLUOROURACIL; GLYCOPROTEIN IB ALPHA; RETROVIRUS VECTOR; TRANSCRIPTION FACTOR NF E2 P45 SUBUNIT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG SYNTHESIS; GENE OVEREXPRESSION; GRANULOCYTE; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MEGAKARYOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; THROMBOCYTE; THROMBOCYTOPOIESIS; UPREGULATION;

ACETYLCHOLINESTERASE; ANIMALS; BLOOD PLATELETS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; ENZYME INDUCTION; GRANULOCYTES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MEGAKARYOCYTES; MICE; MICE, INBRED C57BL; MYELOPOIESIS; NF-E2 TRANSCRIPTION FACTOR, P45 SUBUNIT; PLOIDIES; RADIATION CHIMERA; RECOMBINANT FUSION PROTEINS; THROMBOPOIESIS; TRANSDUCTION, GENETIC;

MURINAE; MUS;

EID: 37249025769     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2007.08.015     Document Type: Article

References (51)

1. Linker C. Thrombopoietin in the treatment of acute myeloid leukemia and in stem-cell transplantation. Semin Hematol 37 (2000) 35-40
2. Neumann T.A., and Foote M. Megakaryocyte growth and development factor (MGDF): an Mpl ligand and cytokine that regulates thrombopoiesis. Cytokines Cell Mol Ther 6 (2000) 47-56
3. Wendling F., Maraskovsky E., Debili N., et al. cMpl ligand is a humoral regulator of megakaryocytopoiesis. Nature 369 (1994) 571-574
4. Kaushansky K., Lok S., Holly R.D., et al. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature 369 (1994) 568-571
5. Debili N., Wendling F., Katz A., et al. The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors. Blood 86 (1995) 2516-2525
6. Guerriero R., Testa U., Gabbianelli M., et al. Unilineage megakaryocytic proliferation and differentiation of purified hematopoietic progenitors in serum-free liquid culture. Blood 86 (1995) 3725-3736
7. Hagiwara T., Kodama I., Horie K., Kato T., and Miyazaki H. Proliferative properties of human umbilical cord blood megakaryocyte progenitor cells to human thrombopoietin. Exp Hematol 26 (1998) 228-235
8. Choi E.S., Hokom M., Bartley T., et al. Recombinant human megakaryocyte growth and development factor (rHuMGDF), a ligand for c-Mpl, produces functional human platelets in vitro. Stem Cells 13 (1995) 317-322
9. Cramer E.M., Norol F., Guichard J., et al. Ultrastructure of platelet formation by human megakaryocytes cultured with the Mpl ligand. Blood 89 (1997) 2336-2346
10. Shivdasani R.A., Fujiwara Y., McDevitt M.A., and Orkin S.H. A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development. EMBO J 16 (1997) 3965-3973
11. Vyas P., Ault K., Jackson C.W., Orkin S.H., and Shivdasani R.A. Consequences of GATA-1 deficiency in megakaryocytes and platelets. Blood 93 (1999) 2867-2875
12. Kim J.A., Jung Y.J., Seoh J.Y., Woo S.Y., Seo J.S., and Kim H.L. Gene expression profile of megakaryocytes from human cord blood CD34(+) cells ex vivo expanded by thrombopoietin. Stem Cells 20 (2002) 402-416
13. Shim M.H., Hoover A., Blake N., Drachman J.G., and Reems J.A. Gene expression profile of primary human CD34+CD38lo cells differentiating along the megakaryocyte lineage. Exp Hematol 32 (2004) 638-648
14. Shivdasani R.A., and Orkin S.H. Erythropoiesis and globin gene expression in mice lacking the transcription factor NF-E2. Proc Natl Acad Sci U S A 92 (1995) 8690-8694
15. Shivdasani R.A., Rosenblatt M.F., Zucker-Franklin D., et al. Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell 81 (1995) 695-704
16. Onodera K., Shavit J.A., Motohashi H., Yamamoto M., and Engel J.D. Perinatal synthetic lethality and hematopoietic defects in compound mafG::mafK mutant mice. EMBO J 19 (2000) 1335-1345
17. Lecine P., Villeval J.L., Vyas P., Swencki B., Xu Y., and Shivdasani R.A. Mice lacking transcription factor NF-E2 provide in vivo validation of the proplatelet model of thrombocytopoiesis and show a platelet production defect that is intrinsic to megakaryocytes. Blood 92 (1998) 1608-1616
18. Levin J., Peng J.P., Baker G.R., et al. Pathophysiology of thrombocytopenia and anemia in mice lacking transcription factor NF-E2. Blood 94 (1999) 3037-3047
19. Shivdasani R.A. Molecular and transcriptional regulation of megakaryocyte differentiation. Stem Cells 19 (2001) 397-407
20. Deveaux S., Cohen-Kaminsky S., Shivdasani R.A., et al. p45 NF-E2 regulates expression of thromboxane synthase in megakaryocytes. EMBO J 16 (1997) 5654-5661
21. Lecine P., Italiano Jr. J.E., Kim S.W., Villeval J.L., and Shivdasani R.A. Hematopoietic-specific beta 1 tubulin participates in a pathway of platelet biogenesis dependent on the transcription factor NF-E2. Blood 96 (2000) 1366-1373
22. Tiwari S., Italiano Jr. J.E., Barral D.C., et al. A role for Rab27b in NF-E2-dependent pathways of platelet formation. Blood 102 (2003) 3970-3979
23. Kerrigan S.W., Gaur M., Murphy R.P., Shattil S.J., and Leavitt A.D. Caspase-12: a developmental link between G-protein-coupled receptors and integrin alphaIIbbeta3 activation. Blood 104 (2004) 1327-1334
24. Nagata Y., Yoshikawa J., Hashimoto A., Yamamoto M., Payne A.H., and Todokoro K. Proplatelet formation of megakaryocytes is triggered by autocrine-synthesized estradiol. [erratum appears in Genes Dev. 2005 Aug 1;19(15):1823]. Genes Dev 17 (2003) 2864-2869
25. Chen Z., Hu M., and Shivdasani R.A. Expression analysis of primary mouse megakaryocyte differentiation and its application in identifying stage-specific molecular markers and a novel transcriptional target of NF-E2. Blood 109 (2007) 1451-1459
26. Yamaguchi Y., Zon L.I., Ackerman S.J., Yamamoto M., and Suda T. Forced GATA-1 expression in the murine myeloid cell line M1: induction of c-Mpl expression and megakaryocytic/erythroid differentiation. Blood 91 (1998) 450-457
27. Sauvageau G., Thorsteinsdottir U., Eaves C.J., et al. Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo. Genes Dev 9 (1995) 1753-1765
28. Kulessa H., Frampton J., and Graf T. GATA-1 reprograms avian myelomonocytic cell lines into eosinophils, thromboblasts, and erythroblasts. Genes Dev 9 (1995) 1250-1262
29. Sayer M.S., Tilbrook P.A., Spadaccini A., et al. Ectopic expression of transcription factor NF-E2 alters the phenotype of erythroid and monoblastoid cells. J Biol Chem 275 (2000) 25292-25298
30. Persons D.A., Allay J.A., Allay E.R., et al. Enforced expression of the GATA-2 transcription factor blocks normal hematopoiesis. Blood 93 (1999) 488-499
31. Bradley T.R., Williams N., Kriegler A.B., Fawcett J., and Hodgson G.S. In vivo effects of interleukin-1 alpha on regenerating mouse bone marrow myeloid colony-forming cells after treatment with 5-fluorouracil. Leukemia 3 (1989) 893-896
32. Randall T.D., and Weissman I.L. Phenotypic and functional changes induced at the clonal level in hematopoietic stem cells after 5-fluorouracil treatment. Blood 89 (1997) 3596-3606
33. Karnovsky M.J., and Roots L.A. A "direct-coloring" thiocholine method for chilinesterases. J Histochem 12 (1964) 219-221
34. Fujimoto T.T., Kohata S., Suzuki H., Miyazaki H., and Fujimura K. Production of functional platelets by differentiated embryonic stem (ES) cells in vitro. Blood 102 (2003) 4044-4051
35. Italiano Jr. J.E., Lecine P., Shivdasani R.A., and Hartwig J.H. Blood platelets are assembled principally at the ends of proplatelet processes produced by differentiated megakaryocytes. J Cell Biol 147 (1999) 1299-1312
36. Ney P.A., Sorrentino B.P., McDonagh K.T., and Nienhuis A.W. Tandem AP-1-binding sites within the human beta-globin dominant control region function as an inducible enhancer in erythroid cells. Genes Dev 4 (1990) 993-1006
37. Talbot D., and Grosveld F. The 5′HS2 of the globin locus control region enhances transcription through the interaction of a multimeric complex binding at two functionally distinct NF-E2 binding sites. EMBO J 10 (1991) 1391-1398
38. Suda T., Suda J., and Ogawa M. Single-cell origin of mouse hemopoietic colonies expressing multiple lineages in variable combinations. Proc Natl Acad Sci U S A 80 (1983) 6689-6693
39. Ogawa M. Effects of hemopoietic growth factors on stem cells in vitro. Hematol Oncol Clin North Am 3 (1989) 453-464
40. Labbaye C., Valtieri M., Barberi T., et al. Differential expression and functional role of GATA-2, NF-E2, and GATA-1 in normal adult hematopoiesis. J Clin Invest 95 (1995) 2346-2358
41. Bord S., Frith E., Ireland D.C., Scott M.A., Craig J.I., and Compston J.E. Estrogen stimulates differentiation of megakaryocytes and modulates their expression of estrogen receptors alpha and beta. J Cell Biochem 92 (2004) 249-257
42. Igarashi K., Kataoka K., Itoh K., Hayashi N., Nishizawa M., and Yamamoto M. Regulation of transcription by dimerization of erythroid factor NF-E2 p45 with small Maf proteins. Nature 367 (1994) 568-572
43. Bestor T.H. Gene silencing as a threat to the success of gene therapy. J Clin Invest 105 (2000) 409-411
44. Challita P.M., and Kohn D.B. Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc Natl Acad Sci U S A 91 (1994) 2567-2571
45. Klug C.A., Cheshier S., and Weissman I.L. Inactivation of a GFP retrovirus occurs at multiple levels in long-term repopulating stem cells and their differentiated progeny. Blood 96 (2000) 894-901
46. Garrick D., Fiering S., Martin D.I., and Whitelaw E. Repeat-induced gene silencing in mammals. Nat Genet 18 (1998) 56-59
47. Martin D.I., and Whitelaw E. The vagaries of variegating transgenes. Bioessays 18 (1996) 919-923
48. Chiang M.Y., and Monroe J.G. BSAP/Pax5A expression blocks survival and expansion of early myeloid cells implicating its involvement in maintaining commitment to the B-lymphocyte lineage. Blood 94 (1999) 3621-3632
49. Sun Y. E3 ubiquitin ligases as cancer targets and biomarkers. Neoplasia 8 (2006) 645-654
50. Duncan S.J., Cooper M.A., and Williams D.H. Binding of an inhibitor of the p53/MDM2 interaction to MDM2. Chem Commun (Camb) 3 (2003) 316-317
51. Chen X., Wen S., Fukuda M.N., et al. Human ITCH is a coregulator of the hematopoietic transcription factor NF-E2. Genomics 73 (2001) 238-241